We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Fluidigm Launches BioMark™ System for High-Throughput Real-Time PCR
Product News

Fluidigm Launches BioMark™ System for High-Throughput Real-Time PCR

Fluidigm Launches BioMark™ System for High-Throughput Real-Time PCR
Product News

Fluidigm Launches BioMark™ System for High-Throughput Real-Time PCR


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Fluidigm Launches BioMark™ System for High-Throughput Real-Time PCR"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Fluidigm Corporation has introduced the BioMark system based on nanofluidic chips for real-time PCR.

Accordingly, the Company has invited scientists engaged in quantitative gene analysis to a web-based event on Thursday, May 10, at 3:00 PM, London time.

The event includes a short presentation by Fluidigm director of R&D, Dr. Marc Unger, and panelist Dr. Rick Gerren of Source MDx, who is a BioMark system user.

According to Company, the chips are known as dynamic arrays, and have important advantages compared to 96-well plates, including: twenty-four times the number of PCR assays per run, significant reductions in reagent costs, less liquid-handling complexity to implement large-scale studies.

The BioMark system is of particular value to scientists who need to simplify the quantitative analysis of 50 to 100 genes against a large number of samples.

BioMark dynamic arrays are tailored for multiplexed gene expression analyses. The array generates 2,304 PCR reactions, requiring orders of magnitude less reagent and liquid transfer steps than traditional formats.

The system also runs BioMark digital arrays, which enable digital PCR - a term established in the scientific literature -which is essential for detection of nucleic acid mutations in a high background of similar sequences. Whereas the practice of digital PCR in microplates has been impractical, it is simple and reliable in Fluidigm digital arrays, the company says.

Advertisement